CJC-1295 w/ DAC Peptide Therapy

CJC-1295 with DAC is a synthetic peptide designed to stimulate growth hormone (GH) release from the pituitary gland. It is a modified version of Growth Hormone Releasing Hormone (GHRH), enhanced with Drug Affinity Complex (DAC) technology to dramatically extend its half-life and activity in the body. This makes it a popular option for those exploring peptide therapy for muscle growth, fat loss, anti-ageing and recovery. At The Catalyst Clinic, we provide expert consultation and personalised peptide therapy, including CJC-1295 with DAC.

What is CJC-1295 w/ DAC?

CJC-1295 is a GHRH analogue that mimics the action of the natural hormone.

  • Stimulates GH release – binds to pituitary receptors and promotes natural growth hormone secretion.

  • Extended duration – the DAC modification binds the peptide to albumin in the blood, protecting it from breakdown.

  • Less frequent dosing – with a half-life of around 6–8 days, it requires far fewer injections than other GHRH peptides.

In simple terms: CJC-1295 with DAC helps the body release more of its own growth hormone, but in a longer-lasting, more convenient way.

Benefits of CJC-1295 w/ DAC

  • • Increased growth hormone levels – supporting lean muscle growth and recovery
  • • Fat reduction – improved fat metabolism and body composition
  • • Better sleep quality – GH plays a role in deep, restorative sleep cycles
  • • Anti-ageing support – improved skin elasticity, collagen production and vitality
  • • Immune support – GH is involved in cellular repair and immune function
  • • Convenient dosing – extended half-life allows for weekly or less frequent administration

How CJC-1295 Works

  • • Acts as a GHRH analogue, binding to pituitary receptors to trigger GH release
  • • DAC technology extends its activity, maintaining stable GH elevation for days rather than hours
  • • Increases IGF-1 levels (through GH release), supporting tissue growth, fat metabolism, and repair

Potential Therapeutic Applications

  • • Growth hormone deficiency
  • • Muscle wasting conditions
  • • Age-related decline in GH
  • • Metabolic health and fat loss
  • • General regenerative and anti-ageing support

Note: CJC-1295 is investigational and not currently licensed as a medical therapy. Clinical supervision is essential.

Safety, Side Effects & Administration

CJC-1295 is generally well tolerated, but possible side effects include:

  • • Water retention
  • • Joint pain or stiffness
  • • Carpal tunnel-like symptoms
  • • Increased appetite

Long-term effects are still under study. At The Catalyst Clinic, peptide therapy is only offered after full consultation and ongoing medical monitoring.

Administration: Typically delivered via subcutaneous injection. Cyclcing of this is essential.

Treatment Process at The Catalyst Clinic

1

Consultation

Full assessment of your goals, health status, and suitability.

2

Tailored Plan

If appropriate, CJC-1295 with DAC may be included in your personalised peptide programme.

3

Ongoing Support

Regular monitoring to ensure effectiveness and safety.

Our clinics in London, New York, and Zurich provide international access to advanced peptide therapy.

 FAQs

  • It is mainly studied for growth hormone support, muscle recovery, fat loss, and anti-ageing applications.

  • CJC-1295 with DAC has a much longer half-life, requiring weekly injections, while CJC-1295 without DAC is short-acting and typically needs daily injections. The addition of DAC prolongs the peptide’s activity in the body by enhancing its binding to albumin.

  • Generally well tolerated, though side effects like water retention and joint discomfort can occur. Long-term safety is still under research.

  • Yes. The Catalyst Clinic offers consultations and supervised peptide therapy including CJC-1295 with DAC at our London clinic.

Book a Consultation

Interested in CJC-1295 with DAC peptide therapy?
Contact The Catalyst Clinic in London, New York, or Zürich today to book your consultation.